| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9721 |
| Human Intestinal Absorption | HIA+ | 0.9949 |
| Caco-2 Permeability | Caco2+ | 0.7146 |
| P-glycoprotein Substrate | Non-substrate | 0.7819 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8142 |
| Non-inhibitor | 0.9822 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8446 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6693 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8110 |
| CYP450 2D6 Substrate | Non-substrate | 0.7399 |
| CYP450 3A4 Substrate | Non-substrate | 0.6802 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9446 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7588 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8918 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7711 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8577 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6293 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9388 |
| Non-inhibitor | 0.9001 |
| AMES Toxicity | Non AMES toxic | 0.9584 |
| Carcinogens | Non-carcinogens | 0.7367 |
| Fish Toxicity | High FHMT | 0.9405 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9772 |
| Honey Bee Toxicity | Low HBT | 0.7273 |
| Biodegradation | Ready biodegradable | 0.8058 |
| Acute Oral Toxicity | III | 0.7891 |
| Carcinogenicity (Three-class) | Non-required | 0.5629 |